Indian Journal of Urology Users online:2890  
IJU
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size

  About Us

  Scope of the Journal

Indian Journal of Urology-IJU (ISSN 0970-1591) is the official publication of the Urological Society of India (USI). The journal was established in 1984 and is published Quarterly in print and electronic formats. It is fully funded by the USI with completely open access and no fees at any stage of publication.

The IJU is the sole Pubmed Central® and SCOPUS indexed urology journal from the Indian subcontinent. The journal receives around 400 submissions every year. Manuscripts are accepted without geographic limitation but with a special focus on regionally relevant issues. The IJU covers content related to all aspects of urology including adult and pediatric urology, andrology, male infertility, urologic oncology, kidney transplantation, and female urology. Accepted manuscripts are published online ‘Ahead of Print’. Over 3000 print copies per issue are mailed to members of USI and individual and institutional subscribers.

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TDNet, Wanfang Data

The journal is indexed with, or included in, the following:
DOAJ, EMBASE/ Excerpta Medica, Emerging Sources Citation Index, Indian Science Abstracts, IndMed, PubMed Central, Scimago Journal Ranking, SCOPUS, Web of Science

Emerging Sources Citation Index 

Journal Ethics

Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp

Open Access Publication and Creative Commons Licensing

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Digital Archiving

Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.

Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.

CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.

Ahead of Print policy

Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.

Advertisements

While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:

  • "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
  • The Editorial Board has full and final approval over the content of all advertisements.
  • Advertisers will never be shown any manuscripts or other content prior to publication.


    Medknow Publications   Top

  Search 
  The Journal 
  The Association 
  Site Statistics 
  Addresses 
  e-Alerts 
  Online Submission 

Submit Articles

Alerts

Join us

Fosfocin